-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Honored by the Cangzhou Lingang Economic Development Zone
Category:
发布时间：2025-02-28
【概要描述】
On February 28, the Cangzhou Lingang Economic and Technological Development Zone held a mobilization conference and summary-and-award ceremony for high-quality development in 2025, at which enterprises that have made outstanding contributions to the zone’s high-quality development were solemnly commended. Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, was honored with the title of “Leading Enterprise in Scientific and Technological Innovation.”
On February 28, the Cangzhou Lingang Economic and Technological Development Zone held a mobilization conference and summary-and-award ceremony for high-quality development in 2025, at which enterprises that have made outstanding contributions to the zone’s high-quality development were solemnly commended. Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group was awarded the title of “Leading Enterprise in Scientific and Technological Innovation.”
In his address as the representative of the honored enterprise, Cui Yongbin, Chairman of Guangxiang Pharmaceutical, stated that the company has proactively seized the strategic opportunities presented by the Beijing–Tianjin–Hebei coordinated development initiative. With strong support from the Lingang Development Zone, Guangxiang Pharmaceutical has taken innovation-driven development as its guiding principle, accelerated the growth of new-quality productive forces, continuously enhanced its integrated “API-plus-formulation” development capabilities, and focused on expanding both domestic and international markets, thereby consistently making new strides in innovative, high-quality corporate development. Currently, Guangxiang Pharmaceutical is undertaking four provincial-level research projects and three municipal-level projects, with more than 70 ongoing projects being expedited, resulting in a significant enhancement of its technological strength and laying a solid foundation for the establishment of a national-level enterprise technology center (sub-center). In 2024, 14 specially developed APIs that have received R&D approval were successfully commercialized and implemented, injecting fresh momentum into the company’s high-quality development. Cui Yongbin emphasized that the company’s growth is inseparable from the park’s favorable innovation ecosystem and conducive development environment. Looking ahead, Guangxiang Pharmaceutical will continue to increase its R&D investment, pursue innovation and strive for higher standards, accelerate its global expansion, and endeavor to build itself into a first-class domestic producer of specialty APIs.
At the meeting, Zhang Jianhua, Secretary of the Party Leadership Group and Director of the Management Committee of the Cangzhou Lingang Economic and Technological Development Zone, solemnly pledged on behalf of all Party members and cadres in the Lingang Industrial Park that optimizing the business environment would be treated as a “never-ending” major project, with unwavering commitment to refraining from unnecessary interference while ensuring prompt response to legitimate requests. He urged all departments to achieve zero-distance communication between government and enterprises, remove all obstacles to policy implementation, ensure full and timely provision of essential resources, resolve issues without delay, and adopt zero tolerance for any behavior that undermines the business environment. He emphasized the need to steadfastly place project development at the “center stage,” ensure that enterprise services enjoy the same priority, and encourage enterprises to strive for the “center stage” in their own development, thereby continuously fostering a world-class business environment that inspires state-owned enterprises to take bold action, private enterprises to innovate boldly, and foreign-invested enterprises to invest boldly.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091